Bavarian Nordic gets new order for 1.5 million monkeypox vaccine doses
After two recent order rounds the past week, and two financial upgrades as a result, the biotech firm has announced a new order for its vaccine against monkeypox from an undisclosed European country.
by marketwire, translated by daniel pedersen
On Tuesday, Bavarian Nordic announced yet another order for its vaccine, approved in the monkeypox indication in the US and Canada, making it the world’s only vaccine for the infectious disease.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
